Nankai Cangzhou Bohai New Area Green Chemical Research Co., Ltd., established on 2019-06-25, Business scope includes general items:Chemical raw materials and products,new material,new energy,Biomedical science and technology research,technology development,technology transfer,Technical Advisory Services,Technology Promotion;Chemical product production(No licensed chemical products);Chemical Products,Specialty Chemicals,catalyst sales(Free of Hazardous Chemicals);Intellectual Property Services;Conference and Exhibition Services;Technology intermediary service;Entrepreneurial business incubation and development services;Entrepreneurial Space Development Services;Analytical Testing Services;House to rent,Equipment rental service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Hangzhou Duanli Biotechnology Co., Ltd., established on 2012-05-23, Business scope includes general items:Cosmetics Wholesale;Cosmetics Retail;R&D and application of cell technology;Engineering and Technology Research and Experimental Development;grocery store(Three small industries);Medical Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Beijing Scitop Bio-tech Co., Ltd. engages in the research and development, production, and sale of compound food additives. It also offers edible probiotic products, and animal and plant probiotic products. The company was founded on September 5, 2003 and is headquartered in Beijing, China.

Ningxia Wolfberry Innovation Center (Co., Ltd.), established on 2020-12-18, Business scope includes other technology promotion service industries;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;R&D and application of cell technology;New material technology research and development;Pesticide registration test;Research and development of biopesticide technology;Bio-organic fertilizer research and development;Research and development of compound microbial fertilizer;Bio-feed R&D;R&D of industrial enzyme preparations;Fermentation process optimization technology research and development;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Resource recycling technology research and development;Research and development of technology for the harmless utilization of agricultural and forestry waste resources;Resource recycling service technical consultation;Intellectual Property Services;Technology intermediary service;(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Huayang Biotechnology Co., Ltd., established on 2019-05-23, Business scope includes general business items:Biochemical and zoological experimental technical services;Technology development of biotechnology products;marketing planning;Import and export of goods and technology;Biochemical experimental equipment and reagents(Free of Hazardous Chemicals),Veterinary equipment,R&D and sales of accessories and consumables;Domestic Trade;Operating import and export business.,The licensing program is:Sales of Veterinary Drugs.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company's lead product, DX-88, has been approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug Administration (FDA) for treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. The Company commercializes KALBITOR on its own in the United States. In addition to its approved commercial use for HAE in the United States, the Company is also developing DX-88 through collaborations in other indications. These include use of DX-88 for the reduction of blood loss during surgery in collaboration with Cubist Pharmaceuticals (Cubist), and for treatment of retinal diseases in collaboration with Fovea Pharmaceuticals (Fovea), which was acquired by sanofi-aventis during the year ended December 31, 2009.

Industry Academic Cooperation Foundation Hallym University is a private company headquartered in the South Korea. The firm provides office support services.

Guodian (Beijing) Pharmaceutical Technology Co., Ltd., established on 2017-12-07, Business scope includes technology development,technical consulting,Technical Services,technology transfer,Technical testing;Medical Research and Experimental Development;health management,Health Advisory(Except for medical treatment activities subject to approval);Engineering and Technology Research and Experimental Development;Sales of chemical products,chemical reagent(Contains no hazardous chemicals),medical instrumentsIkind,medical instrumentsIIkind,Instrumentation;Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Beijing Mingze Zhonghe Pharmaceutical Research Co., Ltd., established on 2014-09-23, The scope of business includes the production of pharmaceuticals(Restricted to engage in production and business activities in other cities);Medical Research and Experimental Development;technology development,transfer,consult,Serve;retail chemical products(Does not contain dangerous chemicals and a class of precursor chemicals);Conference Services(No board and lodging);Production of chemical raw materials,Chemical Products(Restricted to engage in production and business activities in other cities)(Market entities independently choose business projects in accordance with the law,Carry out business activities;production of medicines(Restricted to engage in production and business activities in other cities)and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.

Sanpu Pharmaceutical Co. Ltd., part of Tibet Rongen Technology Co. Ltd., is a Chinese company located in Xining. The firm manufactures pharmaceutical products. It was acquired by Kunming Yuxin Pharmaceutical Merging Investment Center LP from Far East Smarter Energy Co., Ltd.

Chuangmo Biotechnology (Beijing) Co. Ltd. is a company headquartered in China that operates as a biotechnology company which researches and develops on tumor and tumor immunopharmacodynamics.

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

Yao Shunze Biomedicine (Nanjing) Co., Ltd., established on 2019-05-27, Business scope includes biomedical technology and product development,Technical Services and Technology Transfer;Technology development of medical devices,technical consulting,Technology Transfer and Technical Services;Pharmaceutical technology development,technical consulting,Technology Transfer and Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

KPC is a pharmaceutical company that engages in the manufacture of pharmaceuticals. Tablets, fluids, ointments, and injectables are among their offerings. Its goal is to improve people's lives by enabling them to achieve more, feel better, and live longer. They have technological machinery, skilled and motivated individuals, and management systems that can handle both quantity and quality of work. They are looking for new ways to improve their performance, raise their integrity to a level of excellence, implement their initiatives, and achieve their goals.